{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:44:51Z","timestamp":1773294291845,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Sleep"],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Type 2 diabetes and sleep disorders are closely connected. We have evaluated a 4-day concentrated transdiagnostic, micro choice-based and interdisciplinary group treatment for patients with type 2 diabetes, with the aim of improving patient activation. We wanted to explore whether sleep problems would decrease after this intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients were assessed pre \u2013 post the intervention by Insomnia Severity Index (ISI), Bergen Insomnia Scale (BIS), Epworth Sleepiness Scale (ESS), Berlin Questionnaire (BQ) at baseline, 3-, 6- and 12 months follow-up, to measure symptoms related to insomnia, Obstructive Sleep Apnoea (OSA) and daytime sleepiness. Seventy-five patients with type 2 diabetes were included in our sample.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At baseline, 41% and 25% had symptoms of insomnia, as defined by the BIS and ISI, respectively. Another 56% were likely to suffer from OSA using the BQ. At follow-up, the intervention was associated with reduction in symptoms of sleep disorders, and the reduction was still significant at 12 months follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although the study was not designed to disentangle how much of the improvement was due to sleep education and medication, the outcome still shows the usefulness of the format also in terms of sleep disorders in type 2 diabetes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frsle.2025.1639626","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:13:51Z","timestamp":1757909631000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Concentrated micro choice-based treatment for type 2 diabetes is associated with decreased risk of sleep apnoea, less daytime sleepiness and lower insomnia symptoms. A non-randomized pre \u2013 post pilot study"],"prefix":"10.3389","volume":"4","author":[{"given":"Ane","family":"Wilhelmsen-Langeland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten Amund","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus R\u00f8d","family":"Kj\u00f8de","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurd William","family":"Hystad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Kvale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirik","family":"S\u00f8fteland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1530\/JOE-21-0155","article-title":"The links between sleep duration, obesity and type 2 diabetes mellitus","volume":"252","author":"Antza","year":"2021","journal-title":"J. Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1389-9457(00)00065-4","article-title":"Validation of the insomnia severity index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/26350106251326517","article-title":"Intermittent use of continuous glucose monitoring in type 2 diabetes is preferred: a qualitative study of patients' experiences","volume":"51","author":"Bendixen","year":"","journal-title":"Sci. Diabetes Self Manag. Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/26350106241304422","article-title":"Experiences with a novel micro-choice-based concentrated group intervention for people with type 2 diabetes: a qualitative study","volume":"51","author":"Bendixen","year":"","journal-title":"Sci. Diabetes Self Manag. Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.pcd.2019.02.002","article-title":"Sleep duration is a significant predictor of cardiac autonomic neuropathy in type 2 diabetes mellitus","volume":"13","author":"Bhati","year":"2019","journal-title":"Prim. Care Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.evalprogplan.2016.12.009","article-title":"Being smart about writing SMART objectives","volume":"61","author":"Bjerke","year":"2017","journal-title":"Eval. Program Plann."},{"key":"B7","doi-asserted-by":"publisher","first-page":"625631","DOI":"10.3389\/fpsyt.2021.625631","article-title":"Does concentrated exposure treatment for obsessive-compulsive disorder improve insomnia symptoms? Results from a randomized controlled trial","volume":"12","author":"Hagen","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B8","unstructured":"IDF Diabetes Atlas 10th Edition\n          \n          2021"},{"key":"B9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1210\/clinem\/dgz065","article-title":"Prevalence of insomnia (symptoms) in T2D and association with metabolic parameters and glycemic control: meta-analysis","volume":"105","author":"Koopman","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e32216","DOI":"10.2196\/32216","article-title":"Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: protocol for a nonrandomized clinical intervention study","volume":"10","author":"Kvale","year":"2021","journal-title":"JMIR Res. Protoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12916-023-03237-3","article-title":"First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study","volume":"22","author":"Kvale","year":"2024","journal-title":"BMC Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/15402002.2021","article-title":"Brief behavioral treatment for insomnia: a meta-analysis","volume":"20","author":"Kwon","year":"2022","journal-title":"Behav. Sleep Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1740774515602688","article-title":"Fallacies of last observation carried forward analyses","volume":"13","author":"Lachin","year":"2016","journal-title":"Clin. Trials"},{"key":"B15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","article-title":"The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.7326\/0003-4819-131-7-199910050-00002","article-title":"Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome","volume":"131","author":"Netzer","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/sjop.12417","article-title":"Sleep disturbances in treatment-seeking OCD-patients: changes after concentrated exposure treatment","volume":"59","author":"Nordahl","year":"2018","journal-title":"Scand. J. Psychol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e3785","DOI":"10.7717\/peerj.3785","article-title":"Factors influencing healthcare provider respondent fatigue answering a globally administered in-app survey","volume":"5","author":"O'Reilly-Shah","year":"2017","journal-title":"PeerJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2466\/pms.107.3.691-706","article-title":"A new scale for measuring insomnia: the Bergen insomnia scale","volume":"107","author":"Pallesen","year":"2008","journal-title":"Percept. Mot. Skills"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.3390\/ijerph18179248","article-title":"Comorbid insomnia and obstructive sleep apnea (COMISA): current concepts of patient management","volume":"18","author":"Ragnoli","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.chest.2017.05.009","article-title":"Obstructive sleep apnea and diabetes: a state of the art review","volume":"152","author":"Reutrakul","year":"2017","journal-title":"Chest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.smrv.2009.04.002","article-title":"The hyperarousal model of insomnia: a review of the concept and its evidence","volume":"14","author":"Riemann","year":"2010","journal-title":"Sleep Med. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e70106","DOI":"10.1111\/dme.70106","article-title":"Diabetes distress and sleep impairment in type 2 diabetes: a population-based cross-sectional study-The HUNT Study, Norway","volume":"2025","author":"Riise","year":"2025","journal-title":"Diabet. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00125-021-05541-0","article-title":"Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature","volume":"64","author":"Schipper","year":"2021","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11325-022-02606-1","article-title":"Potential use of SGLT-2 inhibitors in obstructive sleep apnea: a new treatment on the horizon","volume":"27","author":"Tanriover","year":"2023","journal-title":"Sleep Breath"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s11325-018-1621-y","article-title":"Quality of life in obstructive sleep apnea is related to female gender and comorbid insomnia","volume":"22","author":"Tasbakan","year":"2018","journal-title":"Sleep Breath"},{"key":"B27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12888-024-05786-0","article-title":"Concentrated transdiagnostic and cross-disciplinary micro-choice based group treatment for patients with depression and with anxiety leads to lasting improvements after 12 months: a pilot study","volume":"24","author":"Wilhelmsen-Langeland","year":"2024","journal-title":"BMC Psychiatry"}],"container-title":["Frontiers in Sleep"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frsle.2025.1639626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:13:54Z","timestamp":1757909634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frsle.2025.1639626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":27,"alternative-id":["10.3389\/frsle.2025.1639626"],"URL":"https:\/\/doi.org\/10.3389\/frsle.2025.1639626","relation":{},"ISSN":["2813-2890"],"issn-type":[{"value":"2813-2890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"1639626"}}